Mark Farber, MD, University of North Carolina Health Care (IMAGE)
Caption
Mark Farber, MD, chief of vascular surgery at the UNC School of Medicine, is the national principal investigator of the study which is being conducted to obtain approval of the device from the US Food and Drug Administration (FDA). The device -- the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE) -- is manufactured by W. L. Gore & Associates, Inc.
Credit
UNC Health Care
Usage Restrictions
None
License
Licensed content